Home » Topics » BioWorld Science

BioWorld Science
RSS

KaloBios inlicenses antibody to treat and prevent Pseudomonas infections

June 9, 2004

Discovery milestone in ChemBridge/Eisai GPCR collaboration

June 9, 2004

Amersham patent covers targeted Tc complexes as MRI agents

June 8, 2004

Abbott claims three series of compounds for epilepsy, migraine and bipolar disorder

June 8, 2004

Anti-IFN-gamma antibodies developed by scientists at Amgen and Medarex

June 8, 2004

Anti-GDF-8 antibodies and their use patented by Wyeth and Cambridge Antibody Technology

June 8, 2004

Agonistic antibodies to Epo receptors and their use as antianemic agents

June 8, 2004

The antidiabetic agent BLX-1002 subject of various presentations at ADA

June 8, 2004

Retinoid X receptor antagonist improves glucose and lipid metabolism in vivo

June 8, 2004

BCX-2798 and BCX-2855 show efficacy against human parainfluenza viruses

June 8, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...